FDA inspection
Synpac-Kingdom Pharmaceutical Co., Ltd. - Taoyuan plant: FDA inspection ending Nov 4, 2022
FDA inspection 1191836 · Voluntary Action Indicated (VAI) · Taoyuan City
Key facts
| Inspection ID | 1191836 |
|---|---|
| Firm | Synpac-Kingdom Pharmaceutical Co., Ltd. - Taoyuan plant |
| FEI number | 3015505405 |
| Address | Chang An Rd., Sec 1, No. 80 Luzhu District |
| City | Taoyuan City |
| Fiscal year | 2023 |
| Inspection end date | Nov 4, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data